Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/16/2014 09/17/2014 09/18/2014 09/19/2014 09/22/2014 Date
5.88(c) 5.91(c) 5.76(c) 5.77(c) 5.62(c) Last
5 394 344 4 671 871 4 303 042 9 628 985 6 245 068 Volume
+1.20% +0.51% -2.54% +0.17% -2.60% Change
More quotes
Company
ARIAD Pharmaceuticals, Inc. operates as a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.The company has four products: Ridaforolimus, Ponatinib, AP1903 and AP26113.Its approach to structure-based drug... 
Sector
Pharmaceuticals
Calendar
11/11Earnings Release
Surperformance© rating of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More about the company
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 62,0 M
EBIT 2014 -215 M
Net income 2014 -215 M
Finance 2014 92,5 M
Yield 2014 -
Sales 2015 160 M
EBIT 2015 -139 M
Net income 2015 -134 M
Finance 2015 97,7 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 15,9x
EV / Sales 2015 6,14x
Capitalization 1 079 M
More Financials
Latest news on ARIAD PHARMACEUTICALS, INC
4d ago ARIAD PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
08/29 ARIAD PHARMACEUTICALS : ARIA) Jumps 5.25% on August 25
08/27 ARIAD PHARMACEUTICALS : Other Events (form 8-K)
08/14 ARIAD PHARMACEUTICALS : Enters into Commercial Pact for Iclusig (Ponatinib) in I..
08/13 ARIAD PHARMACEUTICALS : Reports Second Quarter 2014 Financial Results and Develo..
08/08 ARIAD PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
08/08 ARIAD PHARMACEUTICALS : Other Events (form 8-K)
08/08 ARIAD PHARMACEUTICALS : Enters into Commercial Agreement for Iclusig (Ponatinib)..
08/06 THE ZACKS ANALYST BLOG HIGHLIGHTS : AbbVie, Shire, ARIAD Pharmaceuticals, Immuno..
08/06 ARIAD PHARMACEUTICALS : Results of Operations and Financial Condition, Regulatio..
08/06 ARIAD PHARMACEUTICALS : Reports Second Quarter 2014 Financial Results and Develo..
08/05 ARIAD PHARMACEUTICALS : Announces Commercial Agreement for Iclusig (Ponatinib) i..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
Ariad Pharmaceuticals, Inc : Income Statement Evolution
More Financials
EPS Revisions
Ariad Pharmaceuticals, Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF